The EMBO Journal · 2018 · 122 citations · 41 references
Life SciencesCell BiologyMolecular BiologyGene ExpressionPathophysiologyRna ProcessingBlood Pressure RegulationCardiovascular Molecular PhysiologyNoncoding Rna BiologyRna EditingRna Editing RegulationRna PolyadenylationRna Editing By Noncoding RnaTransfer Rna Editing
Epitranscriptomic events such as adenosine-to-inosine (A-to-I) RNA editing by ADAR can recode mRNAs to translate novel proteins. Editing of the mRNA that encodes actin crosslinking protein Filamin A (FLNA) mediates a Q-to-R transition in the interactive C-terminal region. While FLNA editing is conserved among vertebrates, its physiological function remains unclear. Here, we show that cardiovascular tissues in humans and mice show massive editing and that FLNA RNA is the most prominent substrate. Patient-derived RNA-Seq data demonstrate a significant drop in FLNA editing associated with cardiovascular diseases. Using mice with only impaired FLNA editing, we observed increased vascular contraction and diastolic hypertension accompanied by increased myosin light chain phosphorylation, arterial remodeling, and left ventricular wall thickening, which eventually causes cardiac remodeling and reduced systolic output. These results demonstrate a causal relationship between RNA editing and the development of cardiovascular disease indicating that a single epitranscriptomic RNA modification can maintain cardiovascular health.
41
The Genotype-Tissue Expression (GTEx) project.
The Perseus computational platform for comprehensive analysis of (prote)omics data
Stefka Tyanova, Tikira Temu, Pavel Sinitcyn et al. · Nature Methods · 2016 · 8.9K citations
Go Totsukawa, Yoshihiko Yamakita, Shigeko Yamashiro et al. · The Journal of Cell Biology · 2000 · 681 citations · Full text
A mammalian RNA editing enzyme
Thorsten Melcher, Stefan Maas, Anne Herb et al. · Nature · 1996 · 541 citations